Rishi Paliwal

Dr. Rishi Paliwal

Nanomedicine and Bioengineering Research Laboratory, Department of Pharmacy, Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh 484886, India

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Journal of Controlled Release
Verified
Journal Article
Closed access
Rishi PaliwalRishi Paliwal
Rishi Paliwal
SPSrinath Palakurthi
Srinath Palakurthi

22 July 2014 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
Rishi PaliwalRishi Paliwal
Rishi Paliwal
RBR. Jayachandra Babu
R. Jayachandra Babu
SPSrinath Palakurthi
Srinath Palakurthi

1 January 2012 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Rishi PaliwalRishi Paliwal
Rishi Paliwal
SPShivani R. Paliwal
Shivani R. Paliwal
GAGovind P. Agrawal
Govind P. Agrawal
SVSuresh P. Vyas
Suresh P. Vyas

10 June 2024 in Nanomedicine
Verified
Journal Article
Closed access
AKAnkaj Kumar
Ankaj Kumar
KVKlaudi K Vaiphei
Klaudi K Vaiphei
NSNaveen Singh
Naveen Singh
SCSri Pada Datta Chigurupati
Sri Pada Datta Chigurupati
Shivani Rai Rai ShivaniShivani Rai Rai Shivani
Shivani Rai Rai Shivani
AGArvind Gulbake
Arvind Gulbake
The nanostructured drug-delivery systems for colon-targeted drug delivery are a promising field of research for localized diseases particularly influencing the colonic region, in other words, ulcerative colitis, Crohn's disease, and colorectal cancer. There are various drug-delivery approaches designed for effective colonic disease treatment, including stimulus-based formulations (enzyme-triggered systems, pH-sensitive systems) and magnetically driven drug-delivery systems. In addition, targeted drug delivery by means of overexpressed receptors also offers site specificity and reduces drug resistance. It also covers GI tract-triggered emulsifying systems, nontoxic plant-derived nanoformulations as advanced drug-delivery techniques as well as nanotechnology-based clinical trials toward colonic diseases. This review gives insight into advancements in colon-targeted drug delivery to meet site specificity or targeted drug-delivery requirements.

19 February 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
AMAanjaneya Mamgain
Aanjaneya Mamgain
RKRameshroo Kenwat
Rameshroo Kenwat
Rishi PaliwalRishi Paliwal
Rishi Paliwal

1 May 2024 in Current Drug Safety
Verified
Journal Article
Closed access
PDF file
SSShalini Shukla
Shalini Shukla
PSPriyanka Sharma
Priyanka Sharma
PGPriya Gupta
Priya Gupta
SPShikha Pandey
Shikha Pandey
RAReshu Agrawal
Reshu Agrawal
Kunjbihari SulakhiyaKunjbihari Sulakhiya
Kunjbihari Sulakhiya
Background: Pharmacovigilance (PV) deals with the detection, collection, assessment, understanding, and prevention of adverse effects associated with drugs. The objective of PV is to ensure the safety of the medicines and patients by monitoring and reporting all adverse drug reactions (ADRs) associated with prescribed medicine usage. Findings have indicated that about 0.2- 24% of hospitalization cases are due to ADRs, of which 3.7% of patients have lethal ADRs. The reasons include the number of prescribed drugs, an increased number of new medicines in the market, an inadequate PV system for ADR monitoring, and a need for more awareness and knowledge about ADR reporting. Severe ADRs lead to enhanced hospital stays, increased treatment costs, risk of death, and many medical and economic consequences. Therefore, ADR reporting at its first instance is essential to avoid further harmful effects of the prescribed drugs. In India, the rate of ADR reporting is less than 1%, whereas worldwide, it is 5% due to a need for more awareness about PV and ADR monitoring among healthcare providers and patients. The main objective of this review is to highlight the current scenario and possible futuristic ways of ADR reporting methods in rural areas of India. We have searched the literature using PubMed, Google scholar, Indian citation index to retrieve the resources related to ADR monitoring and reporting in India's urban and rural areas. Spontaneous reporting is the most commonly used PV method to report ADRs in India's urban and rural areas. Evidence revealed that no effective ADR reporting mechanisms developed in rural areas causing underreporting of ADR, thus increasing the threat to the rural population. Hence, PV and ADR reporting awareness among healthcare professionals and patients, telecommunication, telemedicine, use of social media and electronic medical records, and artificial intelligence are the potential approaches for prevention, monitoring, and reporting of ADRs in rural areas.